After decades of apathy, blunders, compounding/track & trace bill done
This article was originally published in Scrip
Executive Summary
There was hardly time for one to blink after the Senate convened on 18 November before the chamber, by a voice vote, passed long-awaited legislation giving the FDA more authority over pharmacy compounders – although not as much as it apparently would like – and establishing a pathway to track drugs through the US supply chain, eventually to the unit level.